MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on February 2, 2005; DOI: 10.1124/mol.104.008748


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.008748v1
67/5/1434    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ponimaskin, E.
Right arrow Articles by Oppermann, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ponimaskin, E.
Right arrow Articles by Oppermann, M.


Received for publication October 29, 2004.
Revised February 2, 2005.
Accepted for publication February 2, 2005.

Palmitoylation of the 5-Hydroxytryptamine(4a) Receptor Regulates Receptor Phosphorylation, Desensitization and {beta}Arrestin mediated Endocytosis

Evgeni Ponimaskin 1*, Aline Dumuis 2, Florence Gaven 2, Gael Barthet 2, Martin Heine 1, Konstantin Glebov 1, Diethelm W. Richter 1, Martin Oppermann 3

1 University Medical school, Gottingen 2 UPR CNRS Montpellier 3 Dept. Immunology, University of Gottingen

* Address correspondence to: E-mail: evgeni{at}ukps.gwdg.de

Abstract

The mouse 5-hydroxytryptamine(4a) (5-HT4(a)) receptor is an unusual member of the G protein-coupled receptor superfamily because it possesses two separate carboxyl-terminal palmitoylation sites which may allow the receptor to adopt different conformations in an agonist-dependent manner. (Ponimaskin et al., (2002) J. Biol. Chem. 277, 2534-2546). By targeted mutation of the proximal (Cys-328/329) or the distal (Cys-386) palmitoylation sites, or a combination of both, we generated 5-HT4(a) receptor variants with distinct functional characteristics. Here we show that upon 5-HT stimulation the 5-HT4(a) receptor undergoes rapid (t1/2 ~ 2 min) and dose-dependent (EC50 ~ 180 nM) phosphorylation on serine residues by a staurosporine-insensitive receptor kinase. Overexpression of GRK2 significantly reduced the receptor promoted cAMP formation. The Cys328/329-Ser mutant, which is constitutively active in the absence of ligand, exhibited enhanced receptor phosphorylation under both basal and agonist-stimulated conditions, and was more effectively desensitized and internalized via a {beta}-arrestin-2 mediated pathway as compared to the wild-type 5-HT4(a). In contrast, G protein activation, phosphorylation, desensitization and internalization of the other palmitoylation-deficient receptor mutants were affected differently. These findings suggest that palmitoylation plays an important role in modulating 5-HT4(a) receptor functions and that G protein activation, phosphorylation, desensitization and internalization depend on the different receptor conformations.


Key words: Serotonin, Desensitization/uncoupling, Sequestration/Internalization, GRKs, barrestins, Phosphorylation/Dephosphorylation





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics